Tags |
|
|
Links |
|
|
Encyclopaedia - An Expert's Escapade, a Cautionary Tale
Call it the case of the Renegade Expert. A federal judge's 78-page order enjoining an expert involved in Zyprexa mass-tort litigation from releasing documents serves as a cautionary tale for any lawyer operating under a judicial gag order.
U
U
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
.S. District Judge Jack B. Weinstein issued the injunction February 13th after an expert retained by plaintiffs in the litigation against drug manufacturer Eli Lilly & Company leaked documents concerning the anti-psychotic drug to the news me
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
ia and others.
Despite having agreed in writing to be bound by the protective order, the expert conspired with a lawyer unconnected to the litigation to come up with a scheme for providing the documents to a New York Times reporter and other
Despite having agreed in writing to be bound by the protective order, the expert conspired with a lawyer unconnected to the litigation to come up with a scheme for providing the documents to a New York Times reporter and other
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
s, Weinstein found.
The expert and the lawyer "deliberately thwarted a federal court's power to effectively conduct civil litigation under the rule of law," the judge said, and therefore "should be enjoined to deter further violations of thi
The expert and the lawyer "deliberately thwarted a federal court's power to effectively conduct civil litigation under the rule of law," the judge said, and therefore "should be enjoined to deter further violations of thi
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
and other courts' orders."
The Alaska Connection
The complex series of events leading up to the order began in October 2006, when the Houston-based Lanier Law Firm, which represents plaintiffs in the litigation, retained Dr. David Egilman
The Alaska Connection
The complex series of events leading up to the order began in October 2006, when the Houston-based Lanier Law Firm, which represents plaintiffs in the litigation, retained Dr. David Egilman
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
to serve as a medical expert.
Earlier, Judge Weinstein, with the consent of the parties, ordered internal Lilly documents sealed in what was designated Case Management Order No. 3, or CMO-3. The order permitted parties to share confidential
Earlier, Judge Weinstein, with the consent of the parties, ordered internal Lilly documents sealed in what was designated Case Management Order No. 3, or CMO-3. The order permitted parties to share confidential
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
aterials with their expert witnesses, provided the experts agreed in writing to adhere to the order.
At the Lanier firm's request, Egilman signed the written agreement to adhere to the protective order. Almost immediately, however, he began
At the Lanier firm's request, Egilman signed the written agreement to adhere to the protective order. Almost immediately, however, he began
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
speaking with New York Times reporter Alex Berenson about how he could provide him with certain protected documents.
At Berenson's suggestion, Weinstein found, Egilman contacted James Gottstein, a lawyer in Alaska unconnected to the Zyprexa
At Berenson's suggestion, Weinstein found, Egilman contacted James Gottstein, a lawyer in Alaska unconnected to the Zyprexa
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
itigation. Agreeing to help Egilman release the documents, Gottstein intervened in an unrelated Alaska case and immediately subpoenaed Egilman to appear for a telephonic deposition and to bring with him all documents in his possession relatin
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
g to 15 drugs, including Zyprexa.
Egilman notified Lilly of the subpoena but not the Lanier lawyers who retained him. Before Lilly could respond, however, the Alaska lawyer obtained an ex parte order amending the subpoena to direct Egilman t
Egilman notified Lilly of the subpoena but not the Lanier lawyers who retained him. Before Lilly could respond, however, the Alaska lawyer obtained an ex parte order amending the subpoena to direct Egilman t
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
provide the documents in advance of the deposition. Egilman informed neither Lilly nor Lanier of this amended order. (Upon learning of these events, the Lanier firm immediately discharged the expert.)
Plugging the Leak
On December 13th, Eg
Plugging the Leak
On December 13th, Eg
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
ilman began sending the documents to Gottstein electronically. Lilly learned of this two days later, but by then the lawyer had already started to forward them to Berenson and others. Lilly immediately informed the special master overseeing d
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
scovery in the Zyprexa litigation. He ordered Gottstein to return the documents. Gottstein replied that he had voluntarily stopped disseminating the documents after having been contacted by Lilly.
On December 17th, a series of articles based
On December 17th, a series of articles based
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
on the documents began to appear in the New York Times. Lilly and the Plaintiffs' Steering Committee jointly petitioned the court for an injunction. After a preliminary injunction was issued on Dec. 29th, Judge Weinstein initiated a hearing
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
n a permanent injunction.
In his order following that hearing, Weinstein made the injunction permanent against Egilman and Gottstein. He declined to enjoin any media outlet or Web site.
Weinstein was particularly harsh in his discussion of
In his order following that hearing, Weinstein made the injunction permanent against Egilman and Gottstein. He declined to enjoin any media outlet or Web site.
Weinstein was particularly harsh in his discussion of
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
the expert. "Here, an expert hired by plaintiffs agreed in writing not to distribute documents sealed by court order," he wrote. "He was given access to those documents so that he could assist plaintiffs – people suffering from serious disabi
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
ities, mental and physical – in pressing their civil suit against defendant, a major pharmaceutical company."
In violation of his legal obligations, Weinstein wrote, the expert "deliberately violated this court's protective order and publish
In violation of his legal obligations, Weinstein wrote, the expert "deliberately violated this court's protective order and publish
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
ed sealed documents, intending that they be widely distributed." The judge noted that the expert "took particular pains to deny Lilly an opportunity to prevent the breach" by making the documents public before Lilly could act.
"Even if one b
"Even if one b
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
lieves, as apparently did the conspirators, that their ends justified their means, courts may not ignore such illegal conduct without dangerously attenuating their power to conduct necessary litigation effectively on behalf of all the people,
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
" Weinstein wrote. "Such unprincipled revelation of sealed documents seriously compromises the ability of litigants to speak and reveal information candidly to each other; these illegalities impede private and peaceful resolution of disputes.
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.encyclopaedia.org.ua/article/126968/encyclopaedia-An-Experts-Escapade-a-Cautionary-Tale.html">An Expert's Escapade, a Cautionary Tale</a>
BB link (for phorums):
[url=http://www.encyclopaedia.org.ua/article/126968/encyclopaedia-An-Experts-Escapade-a-Cautionary-Tale.html]An Expert's Escapade, a Cautionary Tale[/url]
Related Articles:
Affiliate Marketing Success Stories - Raising An Affiliate Program Cash Cow Part 1
Wedding Loans For A Memorable Day Can Add Four Stars To Your Celebrations
Bookmark it:
|